Abstract
Focal segmental glomerulosclerosis (FSGS) is a histological lesion with many causes, including inherited genetic defects, with significant proteinuria being the predominant clinical finding at presentation. FSGS is considered as a podocyte disease due to the fact that in the majority of patients with FSGS, the lesion results from defects in the podocyte structure. However, FSGS does not result exclusively from podocyte-associated genes. In this study, we used a genetic approach based on targeted next-generation sequencing (NGS) of 242 genes to identify the genetic cause of FSGS in seven Tunisian families. The sequencing results revealed the presence of eight distinct mutations including seven newly discovered ones: the c.538G>A (p.V180M) in NPHS2, c.5186G>A (p.R1729Q) in PLCE1 and c.232A>C (p.I78L) in PAX2 and five novel mutations in COL4A3 and COL4A4 genes. Four mutations (c.209G>A (p.G70D), c.725G>A (p.G242E), c.2225G>A (p.G742E), and c. 1681_1698del) were detected in COL4A3 gene and one mutation (c.1424G>A (p.G475D)) was found in COL4A4. In summary, NGS of a targeted gene panel is an ideal approach for the genetic testing of FSGS with multiple possible underlying etiologies. We have demonstrated that not only podocyte genes but also COL4A3/4 mutations should be considered in patients with FSGS.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Preston R, Stuart HM, Lennon R. Genetic testing in steroid-resistant nephrotic syndrome: why, who, when and how? Ped Nephrol. 2019;34:195–210.
McCarthy HJ, Agnieszka B, Matt W, Milos O, Larissa K, Shivaram H, et al. Simultaneous sequencing of 24 genes associated with steroid-resistant nephrotic syndrome. Clin J Am Soc Nephrol. 2013;8:637–48.
Xie J, Chen N. Primary glomerulonephritis in mainland china: an overview. Contrib Nephrol. 2013;181:1–11.
Diouf B, Ka EF, Niang A, Mbengue M, Ka MM, Diouf ML, et al. Analysis of 115 kidney biopsies performed in Dakar (Senegal). Dakar Med. 2001;46:51–3.
Arogundade F. Kidney transplantation in a low-resource setting: Nigeria experience. Kidney Int Suppl. 2013;3:241–45.
D’Agati VD, Fogo AB, Bruijn JA, Charles Jennette J. Pathologic classification of focal segmental glomerulosclerosis: a working proposal. Am J Kidney Dis. 2004;43:368–82.
D’Agati VD, Kaskel FJ, Falk RJ. Focal segmental glomerulosclerosis. N. Engl J Med. 2011;365:2398–411.
Lepori N, Zand L, Sethi S, Fernandez-Juarez G, Fervenza FC. Clinical and pathological phenotype of genetic causes of focal segmental glomerulosclerosis in adults. Clin Kidney J. 2018;11:179–90.
Maggie Chen Y, Liapis H. Focal segmental glomerulosclerosis: molecular genetics and targeted therapies. BMC Nephrol. 2015;16:101.
Akchurin O, Reidy KJ. Genetic causes of proteinuria and nephrotic syndrome: Impact on podocyte pathobiology. Ped Nephrol. 2015;30:221–33.
Bullich G, Trujillano D, Santín S, Ossowski S, Mendizábal S, Fraga G, et al. Targeted next-generation sequencing in steroid-resistant nephrotic syndrome: mutations in multiple glomerular genes may influence disease severity. Eur J Hum Genet. 2015;23:1192–99.
Weins A, Kenlan P, Herbert S, Le TC, Villegas I, Kaplan BS, et al. Mutational and biological analysis of α-actinin-4 in focal segmental glomerulosclerosis. J Am Soc Nephrol. 2005;16:3694–3701.
Gigante M, Pontrelli P, Montemurno E, Roca L, Aucella F, Penza R, et al. CD2AP mutations are associated with sporadic nephrotic syndrome and focal segmental glomerulosclerosis (FSGS). Nephrol Dial Transplant. 2009;24:1858–64.
Brown EJ, Schlöndorff JS, Becker DJ, Tsukaguchi H, Tonna SJ, Uscinski AL, et al. Mutations in the formin protein INF2 cause focal segmental glomerulosclerosis. Nat Genet. 2010;42:72–6.
Xie J, Hao X, Azeloglu EU, Ren H, Wang Z, Ma J, et al. Novel mutations in the inverted formin 2 gene of chinese families contribute to focal segmental glomerulosclerosis. Kidney Int. 2015;88:593–604.
Boute N, Gribouval O, Roselli S, Benessy F, Lee H, Fuchshuber A, et al. NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome. Nat Genet. 2000;24:349–54.
Weber S, Gribouval O, Esquivel EL, Morinière V, Tête M, Legendre CH, et al. NPHS2 mutation analysis shows genetic heterogeneity of steroid-resistant nephrotic syndrome and low post-transplant recurrence. Kidney Int. 2004;66:571–79.
Ismaili KH, Pawtowski A, Boyer O, Martin Wissing K, Janssen F, Hall M. Genetic forms of nephrotic syndrome: a single-center experience in brussel. Ped Nephrol. 2009;24:287–94.
Benhaj Mbarek I, Abroug S, Omezzine A, Pawtowski A, Claire Gubler M, Bouslama A, et al. Novel mutations in steroid-resistant nephrotic syndrome diagnosed in tunisian children. Ped Nephrol. 2011;26:241–49.
Roselli S, Gribouval O, Boute N, Sich M, Benessy F, Attié F, et al. Podocin localizes in the kidney to the slit diaphragm area. Am J Pathol. 2002;160:131–39.
Antignac C. Molecular basis of steroid-resistant nephrotic syndrome. Nefrologia. 2005;25:25–8.
Bouchireb K, Boyer O, Gribouval O, Nevo F, Huynh-Cong E, Morinière V, et al. NPHS2 mutations in steroid-resistant nephrotic syndrome: a mutation update and the associated phenotypic spectrum. Hu Mutat. 2014;35:178–86.
Sprangers B, Meijers B, Appel G. FSGS: diagnosis and diagnostic work-up. Biomed Res Int. 2016;2016:4632768.
Santín S, Bullich G, Tazón-Vega B, García-Maset R, Giménez I, Silva I, et al. Clinical utility of genetic testing in children and adults with steroid-resistant nephrotic syndrome. Clin J Am Soc Nephrol. 2011;6:1139–48.
Hinkes B, Wiggins RC, Gbadegesin R, Vlangos CHN, Seelow D, Nürnberg G, et al. Positional cloning uncovers mutations in PLCE1 responsible for a nephrotic syndrome variant that may be reversible. Nat Genet. 2006;38:1397–405.
Boyer O, Benoit G, Gribouval O, Nevo F, Tête MJ, Dantal J, et al. Mutations in INF2 are a major cause of autosomal dominant focal segmental glomerulosclerosis. J Am Soc Nephrol. 2011;22:239–45.
Barua M, Stellacci E, Stella L, Weins A, Genovese G, Muto V, et al. Mutations in PAX2 associate with adult-onset FSGS. J Am Soc Nephrol. 2014;25:1942–53.
Pochet JM, Bobrie G, Landais P, Goldfarb B, Grünfeld JP. Renal prognosis in Alport’s and related syndromes: influence of the mode of inheritance. Nephrol Dial Transplant. 1989;4:1016–21.
Longo I, Scala E, Mari F, Caselli R, Pescucci R, Antonietta Mencarelli M, et al. Autosomal recessive alport syndrome: an in-depth clinical and molecular analysis of five families. Nephrol Dial Transplant. 2006;21:665–71.
Abrahamson DR, Hudson BG, Stroganova L, Borza DB, St John PL. Cellular origins of type IV collagen networks in developing glomeruli. J Am Soc Nephrol. 2009;20:1471–79.
Groopman EE, Marasa M, Cameron-Christie S, Petrovski S, Aggarwal VS, Milo-Rasouly, et al. Diagnostic utility of exome sequencing for kidney disease. N. Engl J Med. 2019;380:42–51.
Voskarides K, Damianou L, Neocleous V, Zouvani I, Christodoulidou S, Hadjiconstantinou V, et al. COL4A3/COL4A4 mutations producing focal segmental glomerulosclerosis and renal failure in thin basement membrane nephropathy. J Am Soc Nephrol. 2007;18:3004–16.
Pierides A, Voskarides K, Athanasiou Y, Ioannou K, Damianou L, Arsali M, et al. Clinico-pathological correlations in 127 patients in 11 large pedigrees, segregating one of three heterozygous mutations in the COL4A3/ COL4A4 genes associated with familial haematuria and significant late progression to proteinuria and chronic kidney disease from focal segmental glomerulosclerosis. Nephrol Dial Transplant. 2009;24:2721–29.
Gibson J, Gilbert RD, Bunyan DJ, Angus EM, Fowler DJ, Ennis S. Exome analysis resolves differential diagnosis of familial kidney disease and uncovers a potential confounding variant. Genet Res. 2013;95:165–73.
Adam J, Connor THMF, Wood K, Lewis D, Naik R, Gale DP, et al. Genetic testing can resolve diagnostic confusion in Alport syndrome. Clin Kidney J. 2014;7:197–200.
Chatterjee R, Hoffman M, Cliften P, Seshan S, Liapis H, Jain H. Targeted exome sequencing integrated with clinicopathological information reveals novel and rare mutations in atypical, suspected and unknown cases of alport syndrome or proteinuria. PLoS ONE. 2013;8:76360.
Yoshida H. ER stress and diseases. FEBS J. 2007;274:630–58.
Rajpar MH, McDermott B, Kung L, Eardley R, Knowles L, Heeran M, et al. Targeted induction of endoplasmic reticulum stress induces cartilage pathology. PLoS Genet. 2009;5:1000691.
Acknowledgements
We are indebted to the patients and their families for their invaluable cooperation and for providing the blood samples. This research was funded by the Tunisian Ministry of Higher Education and Scientific Research.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Ammar, S., Kanoun, H., Kammoun, K. et al. Next-generation sequencing in patients with familial FSGS: first report of collagen gene mutations in Tunisian patients. J Hum Genet 66, 795–803 (2021). https://doi.org/10.1038/s10038-021-00912-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s10038-021-00912-2